One Stop Shop for All Your Market Research Reports

Prothrombin Complex Concentrate(PCC) Market, Global Outlook and Forecast 2023-2029

Mainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) including: coagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitamin K deficiency; patients with hemorrhage caused by liver disease need to correct coagulation dysfunction; when disseminated intravascular coagulation (DIC) occurs, coagulation factors II, VII, IX, and X are consumed in large quantities, which can be used in heparin Application after chemotherapeutic; prothrombin time prolongation due to various reasons and intended for surgery, but may be ineffective for those with coagulation factor V deficiency; treatment of bleeding symptoms in patients with hemophilia A who have produced factor VIII preparations ; Reversal of coumarin anticoagulant-induced bleeding. This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate(PCC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate(PCC). This report contains market size and forecasts of Prothrombin Complex Concentrate(PCC) in global, including the following market information: Global Prothrombin Complex Concentrate(PCC) Market Revenue, 2018-2023, 2024-2029, ($ millions) Global Prothrombin Complex Concentrate(PCC) Market Sales, 2018-2023, 2024-2029, (K Units) Global top five Prothrombin Complex Concentrate(PCC) companies in 2022 (%) The global Prothrombin Complex Concentrate(PCC) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million. 100IU Segment to Reach $ Million by 2029, with a % CAGR in next six years. The global key manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS, Biotest, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, WEIGUANG BIOLOGICAL, Green Cross and BOHUI, etc. in 2022, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prothrombin Complex Concentrate(PCC) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Prothrombin Complex Concentrate(PCC) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units) Global Prothrombin Complex Concentrate(PCC) Market Segment Percentages, by Type, 2022 (%) 100IU 200IU 300IU 400IU 1000IU Global Prothrombin Complex Concentrate(PCC) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units) Global Prothrombin Complex Concentrate(PCC) Market Segment Percentages, by Application, 2022 (%) Hopistial Clinic Others Global Prothrombin Complex Concentrate(PCC) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units) Global Prothrombin Complex Concentrate(PCC) Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Prothrombin Complex Concentrate(PCC) revenues in global market, 2018-2023 (Estimated), ($ millions) Key companies Prothrombin Complex Concentrate(PCC) revenues share in global market, 2022 (%) Key companies Prothrombin Complex Concentrate(PCC) sales in global market, 2018-2023 (Estimated), (K Units) Key companies Prothrombin Complex Concentrate(PCC) sales share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: CSL Beijing Tiantan Biological Products SHANGHAI RAAS Biotest Taibang Biologic Group HUALAN BIOLOGICAL ENGINEERING WEIGUANG BIOLOGICAL Green Cross BOHUI Guangdong Shuanglin Biopharmaceutical Jiangxi Boya Bio-Pharmaceutical Outline of Major Chapters: Chapter 1: Introduces the definition of Prothrombin Complex Concentrate(PCC), market overview. Chapter 2: Global Prothrombin Complex Concentrate(PCC) market size in revenue and volume. Chapter 3: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Prothrombin Complex Concentrate(PCC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Prothrombin Complex Concentrate(PCC) capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 Prothrombin Complex Concentrate(PCC) Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Prothrombin Complex Concentrate(PCC) Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3250
Multi User US $4225
Corporate User US $4875
About this Report
Report ID 946729
Category
  • Pharmaceuticals and Healthcare
Published on 10-Jan
Number of Pages 76
Publisher Name Market Monitor Global
Editor Rating
★★★★★
★★★★★
(57)